VOICED : Pfizer asegura que su vacuna anticovid para niños supera el 90% de eficacia

Pfizer announced that its COVID-19 vaccine is over 90% effective in preventing symptomatic cases in children aged 5 to 11. The FDA is set to review this data to decide on authorization. The study involved 2,250 participants and was conducted during the prevalence of the delta variant. No severe COVID-19 cases or rare side effects like myocarditis were observed, though the sample size was not large enough to detect very rare side effects. The vaccine dose for children is 10 micrograms, compared to 30 micrograms for older groups. The US government is prepared to start vaccinating children once authorized.

What new insight or understanding did you gain from this video?